Agilent Technologies said that it will acquire privately held clinical pathology firm Biocare Medical in an all-cash deal of $950 million
Search Results: pharmaceutical companies (245)
Tariffs may rise and fall with political cycles. Administrations will change. But structural competitiveness endures.
The estimate of $134 billion reflects the total tariff revenue collected under the policy framework that the Supreme Court ruled was not authorized by statute. Trump said people would be getting refunds checks for the savings from the tariffs but what about the overpayments?
The US trade deficit surged 33% in December to $70.3B, ending 2025 near 2024 levels despite months of shifting Trump tariff policies.
FDA Commissioner Marty Makary says he believes “everything should be over the counter” unless a drug is unsafe, addictive or requires monitoring
FDA to reconsider GRAS status of ultra processed foods, corn syrup, amid obesity and safety concerns raised by RFK Jr.
Data is the core asset that drives value creation, and that value ultimately resides with the owner of the data.
The White House announced a major step forward in United States-India economic relations, announcing the trade deal through join statement
Forbes 30 Under 30 fintech CEO Gökçe Güven charged with fraud over false investor claims and visa misconduct.
Alum Dinesh Patel developing blockbuster new drug treatments gives back to Rutgers to support its chemistry lab
India and the European Union have finalized a major trade agreement that could reshape global commerce, strengthen political ties.
Wearable health devices may soon operate under looser regulatory oversight following new guidance from the FDA
Healthcare in 2025 saw rapid innovation, rising costs, ACA subsidy expiration, AI adoption, consolidation, and affordability challenges.
Shah, whose company developed the oral testosterone drug Kyzatrex, urged regulators to broaden treatment access and align policy with modern science and preventive healthcare goals.
Eli Lilly has become the first healthcare company to hit a $1 trillion market value, entering an exclusive club dominated by tech companies
JPMorgan Chase has announced a decade-long initiative to finance and invest directly in companies deemed vital to U.S. interests
Jeff Bezos calls artificial intelligence an “industrial bubble,” noting that while hype fuels overvaluation, AI’s real innovations will ultimately transform industries and benefit society.
President Trump’s push to tighten H-1B visa rules may accelerate offshoring, with U.S. companies turning to India’s 1,700 global capability centers to handle finance, R&D, and more, economists warn.
Dr. Bijoy Sagar of Bayer outlines how responsible, AI-first innovation in pharma and agriculture can drive efficiency, equity, and transformative change for “health for all, hunger for none.”
The U.S. has revoked visas of Indian executives tied to fentanyl precursor exports, signaling tougher scrutiny on India’s chemical sector amid global efforts to curb opioid trafficking.
The Trump administration is considering a $550 billion Japan-backed plan to boost U.S. manufacturing through infrastructure, semiconductors, energy, pharmaceuticals, and critical technology projects.
The UK secures £150 billion ($193.5 billion) in U.S. investments during Trump’s state visit, boosting AI, cloud, life sciences, and digital infrastructure with 7,600 jobs.
Novo Nordisk will cut 9,000 jobs, about 11.5% of its global workforce, as new CEO Maziar Mike Doustdar launches a major restructuring to boost growth.
With the global AI market set to soar from $390 billion to $1.8 trillion by 2030, the next five years will define winners and losers in a new AI-native economy.
U.S. Treasury Secretary Scott Bessent dismissed concerns over India’s rupee challenging the dollar, as the currency struggles at record lows amid tariffs, trade pressures, and global volatility.